» Articles » PMID: 26870794

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium

Abstract

Background: The high relapse and mortality rate of small-cell lung cancer (SCLC) fuels the need for epidemiologic study to aid in its prevention.

Methods: We included 24 studies from the ILCCO collaboration. Random-effects panel logistic regression and cubic spline regression were used to estimate the effects of smoking behaviors on SCLC risk and explore their non-linearity. Further, we explored whether the risk of smoking on SCLC was mediated through COPD.

Findings: Significant dose-response relationships of SCLC risk were observed for all quantitative smoking variables. Smoking pack-years were associated with a sharper increase of SCLC risk for pack-years ranged 0 to approximately 50. The former smokers with longer cessation showed a 43%quit_for_5-9 years to 89%quit_for_≥ 20 years declined SCLC risk vs. subjects who had quit smoking < 5 years. Compared with non-COPD subjects, smoking behaviors showed a significantly higher effect on SCLC risk among COPD subjects, and further, COPD patients showed a 1.86-fold higher risk of SCLC. Furthermore, smoking behaviors on SCLC risk were significantly mediated through COPD which accounted for 0.70% to 7.55% of total effects.

Interpretation: This is the largest pooling study that provides improved understanding of smoking on SCLC, and further demonstrates a causal pathway through COPD that warrants further experimental study.

Citing Articles

Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib.

Cheng K, Zhu Y, Sang R, Kuang Z, Cao Y Front Oncol. 2025; 15:1453066.

PMID: 40040728 PMC: 11876032. DOI: 10.3389/fonc.2025.1453066.


Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival.

Canale M, Urbini M, Petracci E, Angeli D, Tedaldi G, Priano I Lung Cancer (Auckl). 2025; 16:11-23.

PMID: 39995768 PMC: 11849429. DOI: 10.2147/LCTT.S492825.


[Exploration and Challenge of Whole Course Follow-up Management Model 
for Small Cell Lung Cancer].

Huang C, Zhou Y, Xu J, Lu W, Tu L, Li Y Zhongguo Fei Ai Za Zhi. 2025; 28(1):47-54.

PMID: 39988439 PMC: 11848691. DOI: 10.3779/j.issn.1009-3419.2025.106.01.


Completing the Puzzle: Determinants, Comorbidities and Complications for Different Lung Cancer Subtypes: A Pilot Study.

Budin C, Cocuz I, Sabau A, Niculescu R, Cazacu C, Ianosi E Life (Basel). 2025; 14(12.

PMID: 39768319 PMC: 11676267. DOI: 10.3390/life14121611.


The causal and mediation effect of chronic obstructive pulmonary disease on lung cancer subtypes: a two-sample mendelian randomization study.

Zhang X, Zhang J, Wang Z Cancer Causes Control. 2024; 36(1):13-19.

PMID: 39276304 DOI: 10.1007/s10552-024-01916-x.


References
1.
Lopez-Cima M, Alvarez-Avellon S, Pascual T, Fernandez-Somoano A, Tardon A . Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias. BMC Cancer. 2012; 12:433. PMC: 3518149. DOI: 10.1186/1471-2407-12-433. View

2.
Raviv S, Hawkins K, DeCamp Jr M, Kalhan R . Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am J Respir Crit Care Med. 2010; 183(9):1138-46. DOI: 10.1164/rccm.201008-1274CI. View

3.
Heck J, Andrew A, Onega T, Rigas J, Jackson B, Karagas M . Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect. 2010; 117(11):1718-23. PMC: 2801179. DOI: 10.1289/ehp.0900566. View

4.
Loriot M, Rebuissou S, Oscarson M, Cenee S, Miyamoto M, Ariyoshi N . Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics. 2001; 11(1):39-44. DOI: 10.1097/00008571-200102000-00005. View

5.
Yang P, Allen M, Aubry M, Wampfler J, Marks R, Edell E . Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005; 128(1):452-62. DOI: 10.1378/chest.128.1.452. View